BOLD vs MCD · P/E 0.1, $24.6M cap vs P/E 23, rev $25.92B
Boundless Bio, Inc. Common Stock (BOLD) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
BOLD does not have a complete income-statement cache yet.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the BOLD and MCD stock pages for the full models.
Not investment advice.